---
figid: PMC3748320__fcimb-03-00045-g0001
figtitle: Modulation of PGE2 by pathogenic bacteria
organisms:
- Escherichia coli
- Staphylococcus aureus
- Mycobacterium tuberculosis
- Pseudomonas aeruginosa
- Salmonella enterica subsp. enterica serovar Typhimurium
- Streptococcus pneumoniae
- Salmonella enterica
- Klebsiella pneumoniae
- Vibrio cholerae
- Mycobacterium tuberculosis variant bovis BCG
- Streptococcus pyogenes
- Mycobacterium tuberculosis H37Rv
- Mycobacterium avium
- Neisseria gonorrhoeae
- Streptococcus sp. group B
- Moraxella bovis
- Burkholderia cepacia
- Burkholderia pseudomallei
- Salmonella enterica subsp. enterica serovar Enteritidis
- Mycobacterium tuberculosis H37Ra
- Salmonella enterica subsp. enterica serovar Dublin
- Vibrio cholerae O1
- Mycobacterium intracellulare
- Vibrio cholerae O139
- Mycobacterium tuberculosis variant bovis BCG str. Phipps
- Mus musculus
- Rattus norvegicus
- Cavia porcellus
- Bos taurus
- Oryctolagus cuniculus
- Homo sapiens
- Human gammaherpesvirus 8
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Mus musculus
- Arabidopsis thaliana
pmcid: PMC3748320
filename: fcimb-03-00045-g0001.jpg
figlink: /pmc/articles/PMC3748320/figure/F1/
number: F1
caption: Modulation of PGE2 by pathogenic bacteria. PGE2synthesis is initiated by
  the release of AA from the lipid cell membrane by the enzyme cPLA2. Either COX-1
  (constitutively expressed) or COX-2 (inducible) can utilize AA as a substrate to
  produce the precursor PGH2. PGH2 is converted to biologically active PGE2 by means
  of the enzyme PGE2 synthase. PGE2 can then readily signal through one of four EP,
  denoted EP1, EP2, EP3, and EP4. Various pathogens influence PGE2 production and
  signaling along different steps of this pathway. Green arrows indicate activation
  of COX-2 or PGES, while red lines indicate inhibition of COX-2 or PGES by select
  pathogens. Blue lines indicate a potential role for EP signaling in pathogen survival.
papertitle: PGE2 suppression of innate immunity during mucosal bacterial infection.
reftext: Mallory Agard, et al. Front Cell Infect Microbiol. 2013;3:45.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8322835
figid_alias: PMC3748320__F1
figtype: Figure
redirect_from: /figures/PMC3748320__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3748320__fcimb-03-00045-g0001.html
  '@type': Dataset
  description: Modulation of PGE2 by pathogenic bacteria. PGE2synthesis is initiated
    by the release of AA from the lipid cell membrane by the enzyme cPLA2. Either
    COX-1 (constitutively expressed) or COX-2 (inducible) can utilize AA as a substrate
    to produce the precursor PGH2. PGH2 is converted to biologically active PGE2 by
    means of the enzyme PGE2 synthase. PGE2 can then readily signal through one of
    four EP, denoted EP1, EP2, EP3, and EP4. Various pathogens influence PGE2 production
    and signaling along different steps of this pathway. Green arrows indicate activation
    of COX-2 or PGES, while red lines indicate inhibition of COX-2 or PGES by select
    pathogens. Blue lines indicate a potential role for EP signaling in pathogen survival.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - COX1
  - PTGS1
  - PTGS2
  - PLA2G4A
  - KAT5
  - COX2
  - MTCO2P12
  - PTGER1
  - PTGER4
  - PTGER2
  - SPAG11B
  - PTGER3
  - Ptgs1
  - Ptgs2
  - Pla2g4a
  - Ptger1
  - Ubap2l
  - Ptger4
  - Ptger2
  - Ptger3
  - Kat5
  - Lypd8l
  - cox1
  - cox2
  - EP1
  - EP3
  - Arachidonic acid
  - PGE
---
